Illustration of flowing blood cells

In a sample of blood, researchers probe for cancer clues

Berkeley bioengineers led by Amy Herr have made an important step towards liquid biopsy technology, which one day could allow patients to monitor their body’s response to cancer therapy through a simple blood draw.